If you’re a wholesale distributor or manufacturer, November 2019 will introduce daunting operational changes with the Drug Supply Chain Security Act (DSCSA) Saleable Returns Verification requirement. The development and management of compliant solutions will require a collaborative approach between manufacturers and wholesalers. In this interview feature, Andrew Meyer at North Carolina Mutual and Dan Walles at TraceLink discuss how wholesalers are preparing for saleable returns and the serialisation and verification challenges faced by wholesale distributors
and manufacturers alike.

Comments are closed.

%d bloggers like this: